How to buy Inovio Pharmaceuticals shares in Ireland | $11.24

Inovio Pharmaceuticals, Inc is a biotechnology business based in the US. Inovio Pharmaceuticals shares (INO) are listed on the NASDAQ and all prices are listed in US Dollars. Inovio Pharmaceuticals employs 190 staff and has a trailing 12-month revenue of around USD$2.1 million.

Sponsored For

Beginners Choice

DEGIRO

Sponsored For

Low-cost Trading

eToro

Sponsored For

Overall Broker

Plus500

How to buy shares in Inovio Pharmaceuticals from Ireland

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Inovio Pharmaceuticals Find the stock by name or ticker symbol: INO. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Inovio Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$11.24, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Inovio Pharmaceuticals, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Inovio Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Compare online brokers to trade stocks, ETFs and CFDs

Warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89 % of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Sort by:

Name	Product	Number of Stocks	CFDs	Shares	Available Markets	Link
DEGIRO		Access to global markets	No	Yes	AU, AT, BE, CA, CH, CZ, DE, DK, ES, FR, FI, GR, HK, HU, IT, JP, NO, PT, PL, IE, SG, SE, TR, UK, US	Go to site More Info	Your capital is at risk.		loading Fetching your data...
eToro		2,000+	Yes	Yes	Worldwide with exception.	Go to site 71% of CFD accounts lose money More Info	CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.		loading Fetching your data...
Plus500		2,000+	Yes	Yes	US, UK, AU, DE, FR, IT, PT, GR, JP, SG, ZA, NL, FI, BE, DK, SE, CH, ES, AT, NO, HU, CZ, IE, PL, HK	Go to site 76.4% of CFD accounts lose money More Info	CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76.4% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

How has coronavirus impacted Inovio Pharmaceuticals's share price?

Since the stock market crash in March caused by coronavirus, Inovio Pharmaceuticals's share price has had significant positive movement.

Its last market close was USD$11.24, which is 66.68% up on its pre-crash value of USD$3.745 and 257.96% up on the lowest point reached during the March crash when the shares fell as low as USD$3.14.

If you had bought USD$1,000 worth of Inovio Pharmaceuticals shares at the start of February 2020, those shares would have been worth USD$1,693.07 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$2,874.63.

Inovio Pharmaceuticals share price

Is it a good time to buy Inovio Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting Inovio Pharmaceuticals shares

There are currently 56.1 million Inovio Pharmaceuticals shares held short by investors – that's known as Inovio Pharmaceuticals's "short interest". This figure is 6.8% up from 52.6 million last month.

There are a few different ways that this level of interest in shorting Inovio Pharmaceuticals shares can be evaluated.

Inovio Pharmaceuticals's "short interest ratio" (SIR)

Inovio Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Inovio Pharmaceuticals shares currently shorted divided by the average quantity of Inovio Pharmaceuticals shares traded daily (recently around 11.8 million). Inovio Pharmaceuticals's SIR currently stands at 4.77. In other words for every 100,000 Inovio Pharmaceuticals shares traded daily on the market, roughly 4770 shares are currently held short.

However Inovio Pharmaceuticals's short interest can also be evaluated against the total number of Inovio Pharmaceuticals shares, or, against the total number of tradable Inovio Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Inovio Pharmaceuticals's short interest could be expressed as 0.33% of the outstanding shares (for every 100,000 Inovio Pharmaceuticals shares in existence, roughly 330 shares are currently held short) or 0.3382% of the tradable shares (for every 100,000 tradable Inovio Pharmaceuticals shares, roughly 338 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Inovio Pharmaceuticals.

Frequently asked questions

• What percentage of Inovio Pharmaceuticals is owned by insiders or institutions?

  Currently 2.166% of Inovio Pharmaceuticals shares are held by insiders and 36.486% by institutions.

• How many people work for Inovio Pharmaceuticals?

  Latest data suggests 190 work at Inovio Pharmaceuticals.

• When does the fiscal year end for Inovio Pharmaceuticals?

  Inovio Pharmaceuticals's fiscal year ends in December.

• Where is Inovio Pharmaceuticals based?

  Inovio Pharmaceuticals's address is: 660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462

• What is Inovio Pharmaceuticals's ISIN number?

  Inovio Pharmaceuticals's international securities identification number is: US45773H2013

• What is Inovio Pharmaceuticals's CUSIP number?

  Inovio Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 371916107